Explorando la conexión entre dolor, edad, sexo, calidad de vida, capacidad funcional y sueño. Un análisis en farmacia comunitaria.

Saved in:
Bibliographic Details
Title: Explorando la conexión entre dolor, edad, sexo, calidad de vida, capacidad funcional y sueño. Un análisis en farmacia comunitaria.
Alternate Title: Exploring the Connection Between Pain, Age, Sex, Quality of Life, Functional Capacity, And Sleep: An Analysis in Community Pharmacy.
Authors: Reyes Estévez, Daniel1 leinad_77@hotmail.com, González Rodríguez, Alicia2, Morcuende Campos, Álvaro3, Córcoles Ferrándiz, María Edelmira4, Merencio Naudin, Eloi5
Source: Farmacéuticos Comunitarios. 7/15/2025, Vol. 17 Issue 3, p69-99. 31p.
Subjects: SLEEP quality, KARNOFSKY Performance Status, STATISTICAL significance, FUNCTIONAL status, CHRONIC pain
Abstract (English): Introduction: Pain has a significant impact on quality of life. Personalized care emerges as a key strategy in pain management. Objectives: To identify the characteristics of patients with acute or chronic pain who visit the community pharmacy (CP) and to analyze the relationships between these characteristics in order to support future research. Material and Methods: A descriptive, observational, cross-sectional, multicenter study was conducted in patients experiencing pain who attended community pharmacies (CPs). The study took place from October 14 to 27, 2019, in 47 CPs across Spain. The variables analyzed included: pain intensity (VAS), type of pain based on duration and diagnosis, type of medication, quality of life (EuroQoL-5D questionnaire), functional capacity (Karnofsky Performance Status), sleep quality (Insomnia Severity Index -- ISI), and satisfaction with treatment. Results: A total of 403 participants were included: 28% were men and 72% women; 39% were over 70 years old, 45% between 40--69 years, and 16% between 18--39 years. Acute pain was reported by 25% of subjects, and chronic pain by 75%; 90% had non-oncological pain. The mean values observed were: VAS 6.1; EuroQoL 8.3; Karnofsky 78.1; and ISI 9.7. The correlational analysis between VAS, EuroQoL-5D, Karnofsky, and ISI, performed using Spearman's correlation coefficient (SC), showed statistically significant correlations: VAS and EuroQoL (SC=0.47; p<0.001), VAS and EuroQoL pain dimension (SC=0.52; p<0.001), VAS and ISI (SC=0.33; p<0.001), and a negative correlation between VAS and Karnofsky (SC=--0.33; p<0.001). Conclusions: Correlations were identified between age and quality of life, as well as between sex and age with functional capacity. Finally, an association was observed between pain intensity (measured using the VAS scale) and indicators of quality of life, sleep quality, and functional capacity. [ABSTRACT FROM AUTHOR]
Abstract (Spanish): Introducción: el dolor tiene un impacto considerable en la calidad de vida. La atención personalizada se presenta como una estrategia para el tratamiento del dolor. Objetivos: identificar las características de los pacientes con dolor agudo/crónico que visitan la farmacia comunitaria (FC) y analizar las relaciones entre ellas para fundamentar investigaciones futuras. Material y métodos: se realizó un estudio descriptivo, observacional, transversal, multicéntrico en pacientes que experimentan dolor que acuden a la FC. Desarrollado del 14 al 27 de octubre de 2019, en 47 FC del territorio español. Las variables analizadas fueron: intensidad del dolor (EVA), tipo de dolor según su duración y diagnóstico, tipo de medicación, calidad de vida (cuestionario EuroQoL-5D), capacidad funcional (test de Karnofsky), calidad del sueño (índice de severidad del insomnio) (ISI), satisfacción con su tratamiento. Resultados: se incluyeron 403 participantes, 28 % fueron hombres y 72 % mujeres, 39 % tenía más de 70 años, 45 % entre 40-69 años, y 16 % entre 18-39 años. El 25 % de los sujetos presentaron dolor agudo y 75 % dolor crónico; el 90 % presentó dolor no oncológico. Los valores medios observados fueron: EVA 6,1; EuroQoL 8,3; Karnofsky 78,1; e ISI 9,7. El análisis correlacional entre EVA, EuroQoL-5D, Karnofsky e ISI, realizado mediante el coeficiente de correlación de Spearman (CS), mostró correlaciones estadísticamente significativas: EVA y EuroQoL (CS=0,47; p<0,001), EVA y área de dolor del EuroQoL (CS=0,52; p<0,001), EVA e ISI (CS=0,33; p<0,001), y una correlación negativa entre EVA y Karnofsky (CS=-0,33; p<0,001). Conclusiones: se identificaron correlaciones entre la edad y la calidad de vida, así como entre el sexo y la edad con la capacidad funcional. Finalmente, se observó una asociación entre la intensidad del dolor (valorada con la escala EVA) y los indicadores de calidad de vida, calidad del sueño y capacidad funcional. [ABSTRACT FROM AUTHOR]
Copyright of Farmacéuticos Comunitarios is the property of Sociedad Espanola de Farmacia Familiar y Comunitaria and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: MedicLatina
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: lth
DbLabel: MedicLatina
An: 187287642
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Explorando la conexi&#243;n entre dolor, edad, sexo, calidad de vida, capacidad funcional y sue&#241;o. Un an&#225;lisis en farmacia comunitaria.
– Name: TitleAlt
  Label: Alternate Title
  Group: TiAlt
  Data: Exploring the Connection Between Pain, Age, Sex, Quality of Life, Functional Capacity, And Sleep: An Analysis in Community Pharmacy.
– Name: Author
  Label: Authors
  Group: Au
  Data: &lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Reyes+Est&#233;vez%2C+Daniel%22&quot;&gt;Reyes Est&#233;vez, Daniel&lt;/searchLink&gt;&lt;relatesTo&gt;1&lt;/relatesTo&gt;&lt;i&gt; leinad_77@hotmail.com&lt;/i&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Gonz&#225;lez+Rodr&#237;guez%2C+Alicia%22&quot;&gt;Gonz&#225;lez Rodr&#237;guez, Alicia&lt;/searchLink&gt;&lt;relatesTo&gt;2&lt;/relatesTo&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Morcuende+Campos%2C+&#193;lvaro%22&quot;&gt;Morcuende Campos, &#193;lvaro&lt;/searchLink&gt;&lt;relatesTo&gt;3&lt;/relatesTo&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22C&#243;rcoles+Ferr&#225;ndiz%2C+Mar&#237;a+Edelmira%22&quot;&gt;C&#243;rcoles Ferr&#225;ndiz, Mar&#237;a Edelmira&lt;/searchLink&gt;&lt;relatesTo&gt;4&lt;/relatesTo&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Merencio+Naudin%2C+Eloi%22&quot;&gt;Merencio Naudin, Eloi&lt;/searchLink&gt;&lt;relatesTo&gt;5&lt;/relatesTo&gt;
– Name: TitleSource
  Label: Source
  Group: Src
  Data: &lt;searchLink fieldCode=&quot;JN&quot; term=&quot;%22Farmac&#233;uticos+Comunitarios%22&quot;&gt;Farmac&#233;uticos Comunitarios&lt;/searchLink&gt;. 7/15/2025, Vol. 17 Issue 3, p69-99. 31p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: &lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22SLEEP+quality%22&quot;&gt;SLEEP quality&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22KARNOFSKY+Performance+Status%22&quot;&gt;KARNOFSKY Performance Status&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22STATISTICAL+significance%22&quot;&gt;STATISTICAL significance&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22FUNCTIONAL+status%22&quot;&gt;FUNCTIONAL status&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22CHRONIC+pain%22&quot;&gt;CHRONIC pain&lt;/searchLink&gt;
– Name: Abstract
  Label: Abstract (English)
  Group: Ab
  Data: Introduction: Pain has a significant impact on quality of life. Personalized care emerges as a key strategy in pain management. Objectives: To identify the characteristics of patients with acute or chronic pain who visit the community pharmacy (CP) and to analyze the relationships between these characteristics in order to support future research. Material and Methods: A descriptive, observational, cross-sectional, multicenter study was conducted in patients experiencing pain who attended community pharmacies (CPs). The study took place from October 14 to 27, 2019, in 47 CPs across Spain. The variables analyzed included: pain intensity (VAS), type of pain based on duration and diagnosis, type of medication, quality of life (EuroQoL-5D questionnaire), functional capacity (Karnofsky Performance Status), sleep quality (Insomnia Severity Index -- ISI), and satisfaction with treatment. Results: A total of 403 participants were included: 28% were men and 72% women; 39% were over 70 years old, 45% between 40--69 years, and 16% between 18--39 years. Acute pain was reported by 25% of subjects, and chronic pain by 75%; 90% had non-oncological pain. The mean values observed were: VAS 6.1; EuroQoL 8.3; Karnofsky 78.1; and ISI 9.7. The correlational analysis between VAS, EuroQoL-5D, Karnofsky, and ISI, performed using Spearman&#39;s correlation coefficient (SC), showed statistically significant correlations: VAS and EuroQoL (SC=0.47; p&lt;0.001), VAS and EuroQoL pain dimension (SC=0.52; p&lt;0.001), VAS and ISI (SC=0.33; p&lt;0.001), and a negative correlation between VAS and Karnofsky (SC=--0.33; p&lt;0.001). Conclusions: Correlations were identified between age and quality of life, as well as between sex and age with functional capacity. Finally, an association was observed between pain intensity (measured using the VAS scale) and indicators of quality of life, sleep quality, and functional capacity. [ABSTRACT FROM AUTHOR]
– Name: Abstract
  Label: Abstract (Spanish)
  Group: Ab
  Data: Introducci&#243;n: el dolor tiene un impacto considerable en la calidad de vida. La atenci&#243;n personalizada se presenta como una estrategia para el tratamiento del dolor. Objetivos: identificar las caracter&#237;sticas de los pacientes con dolor agudo/cr&#243;nico que visitan la farmacia comunitaria (FC) y analizar las relaciones entre ellas para fundamentar investigaciones futuras. Material y m&#233;todos: se realiz&#243; un estudio descriptivo, observacional, transversal, multic&#233;ntrico en pacientes que experimentan dolor que acuden a la FC. Desarrollado del 14 al 27 de octubre de 2019, en 47 FC del territorio espa&#241;ol. Las variables analizadas fueron: intensidad del dolor (EVA), tipo de dolor seg&#250;n su duraci&#243;n y diagn&#243;stico, tipo de medicaci&#243;n, calidad de vida (cuestionario EuroQoL-5D), capacidad funcional (test de Karnofsky), calidad del sue&#241;o (&#237;ndice de severidad del insomnio) (ISI), satisfacci&#243;n con su tratamiento. Resultados: se incluyeron 403 participantes, 28 % fueron hombres y 72 % mujeres, 39 % ten&#237;a m&#225;s de 70 a&#241;os, 45 % entre 40-69 a&#241;os, y 16 % entre 18-39 a&#241;os. El 25 % de los sujetos presentaron dolor agudo y 75 % dolor cr&#243;nico; el 90 % present&#243; dolor no oncol&#243;gico. Los valores medios observados fueron: EVA 6,1; EuroQoL 8,3; Karnofsky 78,1; e ISI 9,7. El an&#225;lisis correlacional entre EVA, EuroQoL-5D, Karnofsky e ISI, realizado mediante el coeficiente de correlaci&#243;n de Spearman (CS), mostr&#243; correlaciones estad&#237;sticamente significativas: EVA y EuroQoL (CS=0,47; p&lt;0,001), EVA y &#225;rea de dolor del EuroQoL (CS=0,52; p&lt;0,001), EVA e ISI (CS=0,33; p&lt;0,001), y una correlaci&#243;n negativa entre EVA y Karnofsky (CS=-0,33; p&lt;0,001). Conclusiones: se identificaron correlaciones entre la edad y la calidad de vida, as&#237; como entre el sexo y la edad con la capacidad funcional. Finalmente, se observ&#243; una asociaci&#243;n entre la intensidad del dolor (valorada con la escala EVA) y los indicadores de calidad de vida, calidad del sue&#241;o y capacidad funcional. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: &lt;i&gt;Copyright of Farmac&#233;uticos Comunitarios is the property of Sociedad Espanola de Farmacia Familiar y Comunitaria and its content may not be copied or emailed to multiple sites without the copyright holder&#39;s express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.&lt;/i&gt; (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=lth&AN=187287642
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.33620/FC.2173-9218.(2025).24
    Languages:
      – Code: spa
        Text: Spanish
    PhysicalDescription:
      Pagination:
        PageCount: 31
        StartPage: 69
    Subjects:
      – SubjectFull: SLEEP quality
        Type: general
      – SubjectFull: KARNOFSKY Performance Status
        Type: general
      – SubjectFull: STATISTICAL significance
        Type: general
      – SubjectFull: FUNCTIONAL status
        Type: general
      – SubjectFull: CHRONIC pain
        Type: general
    Titles:
      – TitleFull: Explorando la conexión entre dolor, edad, sexo, calidad de vida, capacidad funcional y sueño. Un análisis en farmacia comunitaria.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Reyes Estévez, Daniel
      – PersonEntity:
          Name:
            NameFull: González Rodríguez, Alicia
      – PersonEntity:
          Name:
            NameFull: Morcuende Campos, Álvaro
      – PersonEntity:
          Name:
            NameFull: Córcoles Ferrándiz, María Edelmira
      – PersonEntity:
          Name:
            NameFull: Merencio Naudin, Eloi
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 07
              Text: 7/15/2025
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 18858619
          Numbering:
            – Type: volume
              Value: 17
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Farmacéuticos Comunitarios
              Type: main
ResultId 1